drugset / Trial / NCT03745807
An Investigational Study of NKTR-214 Combined With Nivolumab in Japanese Participants With Advanced Solid Tumors
Phase 1
Completed
3 enrolled
Bristol-Myers Squibb
Nektar Therapeutics · collabOno Pharmaceutical Co., Ltd. · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the safety and tolerability of NTKR-214 in combination with nivolumab in Japanese participants with advanced malignant tumors.
Timeline
- Start
- 2019-04-09
- Primary completion
- 2019-12-18
- Completion
- 2019-12-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bempegaldesleukin | Protein / enzyme biologic | — | — |
| Subject | Nivolumab | Monoclonal antibody | — | — |